| Name |
Spamecal 2,5 mg filmom obložene tablete |
| Marketing Authorisation Number |
HR-H-943817213 |
| Active Substance |
frovatriptansukcinat hidrat |
| Composition |
jedna filmom obložena tableta sadrži 2,5 mg frovatriptana (u obliku frovatriptansukcinat hidrata) |
| Pharmaceutical Form |
Filmom obložena tableta |
| Manufacturer |
Chanelle Medical Unlimited Company, Loughrea, Co. Galway, Irska |
| Marketing Authorisation Holder |
Besta Med EOOD, Ulitsa Kincho Skorchev 8, Tryavna, Oblast Gabrovo, Bugarska |
| Marketing Authorisation Date |
28.02.2024 |
| MA Period of Validity |
28.02.2029 |
| Classification Number |
UP/I-530-09/23-01/256 |
| Registration Number |
381-12-01/286-24-08 |
| Prescription |
Medicinal product subject to medical prescription |
| Type of prescription |
Medicinal product on medical prescription for renewable delivery
|
| Distribution |
Supply through pharmacies (community) |
| Advertising to general public |
not allowed |
| ATC Code |
N02CC07 |
| Marketing status |
Marketed |
| Shortage status |
No shortage |
| SmPC |
download |
| PL |
download |
| Public Assessment Report |
download
|
